COMP <GO>
CVEO vs PG // ENTERPRISE SCALE & MARKET CAP
Civeo Corporation (Canada) (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: CVEO 0
— PG 12
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PG
LAST: $30.55 (+1.09%) • MKT CAP: $315.8M
market-cap
$315.8M
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
market-cap
$372.21B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVEO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVEO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.70% | 51.20% | -27.50 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.90% | 25.40% | -24.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.8x | 16.2x | +6.60 | PG | /valuation <GO> |
| Free Cash Flow Yield | 0.68% | 3.77% | -3.09 | PG | /fcf-yield <GO> |
| Operating Margin | 0.60% | 24.30% | -23.70 | PG | /operating-margins <GO> |
| Net Profit Margin | -3.10% | 19.00% | -22.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -6.30% | 0.30% | -6.60 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.09% | 2.65% | -1.56 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.5 | 60.3 | -11.80 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $315.8M | $372.21B | -$371.90B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVEO REV | PG REV | CVEO GROSS % | PG GROSS % | CVEO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $638.8M | $84.28B | 23.7% | 51.2% | $2.1M | $14.04B |
| FY 2024 | $682.1M | $84.04B | 21.9% | 51.4% | $57.4M | $16.52B |
| FY 2023 | $700.8M | $82.01B | — | — | $96.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVEO // BETA —
PG // BETA 0.87